Within the National Health Service (NHS) in the United Kingdom (UK), the term ‘healthcare support worker’ (hereafter HCSW) has been used as an umbrella term for a variety of ‘unregistered’ healthcare support roles, including healthcare assistant, nursing auxiliary, occupational therapy assistant, who work under the supervision of ‘registered’ staff such as nurses and allied health professionals (Griffin, Citation2023).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by K. E. Harman
Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management
Introduction Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are immunobullous disorders that are clinically significant because they can lead to high morbidity and mortality if left untreated.1 Their diagnosis is often delayed.2 Because their pathophysiology is driven by an autoimmune process, the autoantibodies are the basis of diagnostic investigations and treatment strategies.
What’s new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies
Background The aim of this two‐part evidence update is to present key findings from systematic reviews (SRs) published or indexed in 2018, summarizing prevention of atopic eczema (AE) and treatment with topical therapies. Part 2 will cover systemic therapies. The details of the search methods can be found at: https://www.nottingham.ac.uk/research/groups/cebd/documents/methodological‐resources/ebu‐protocol.pdf.
Alopecia universalis‐like hair loss in acrodermatitis enteropathica
CPD ● A memorable patient A. Shah Corresponding Author E-mail address: amnashahmirza@gmail.com Department of Dermatology, Leicester Royal Infirmary, Leicester, UK *Correspondence: Dr Amna Shah, Department of Dermatology, Leicester Royal Infirmary, Infirmary Square, Leicester, UK Email: amnashahmirza@gmail.com Search for more papers by this author Get access to the full version of this article. View access options below.
What’s new in atopic eczema? An analysis of systematic reviews published in 2017. Part 2: epidemiology, aetiology and risk factors
Review Article What’s new in atopic eczema? An analysis of systematic reviews published in 2017. Part 2: epidemiology, aetiology and risk factors G. Hale Corresponding Author E-mail address: gordon.hale@sth.nhs.uk Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK Correspondence: Dr Gordon Hale, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, S10 2JF, UK.
What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention - Wernham - - Clinical and Experimental Dermatology - Wiley Online Library
Review Article What's new in atopic eczema? An analysis of systematic reviews published in 2017. Part 1: treatment and prevention A. G. H. Wernham Corresponding Author E-mail address: aaron.wernham@nhs.net https://orcid.org/0000-0001-5920-6888 Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, UK *Correspondence: Dr Aaron Wernham, Centre of Evidence Based Dermatology, University of Nottingham, King's Meadow Campus, Lenton Lane, Nottingham, NG7 2NR, UK.
Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management - Melchionda - - Clinical and Experimental Dermatology - Wiley Online Library
Review Article Pemphigus vulgaris and pemphigus foliaceus: an overview of the clinical presentation, investigations and management K. E. Harman Corresponding Author E-mail address: karenharman@doctors.org.uk Department of Dermatology, Leicester Royal Infirmary, Leicester, UK *Correspondence: Dr Karen Harman, Department of Dermatology, Leicester Royal Infirmary, Infirmary Square, Leicester, LE1 5WW, UK.
Sporadic pemphigus foliaceus and class II human leucocyte antigen allele associations in the white British and Indo‐Asian populations in the UK
Pemphigus foliaceus (PF) has both genetic and environmental susceptibility factors. Current data on human leucocyte antigen (HLA) in patients with sporadic PF are limited. To better define the distribution of HLA alleles in patients with PF in the UK. We recruited 36 patients [26 of white British (WB) descent, 10 of Indo‐Asian (IA) descent] with PF who were living in the UK and 159 ethnically matched normal controls, and analysed their class II HLA DRB1 and DQB1 allele distribution.
Orf - a potential trigger for self-limiting epidermolysis bullosa acquisita-like blistering
Previous article in issue: Automated diagnosis: shedding the light on skin cancer Previous article in issue: Automated diagnosis: shedding the light on skin cancer Next article in issue: Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers? Next article in issue: Ulcerative colitis: yet another paradoxical effect of tumour necrosis factor blockers?
Orf - a potential trigger for self‐limiting epidermolysis bullosa acquisita‐like blistering
Forgot your password? Enter your email address below. If your address has been previously registered, you will receive an email with instructions on how to reset your password. If you don't receive an email, you should register as a new user Please check your email for your password reset instructions.
Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Network's STOP GAP and BLISTER trials - Batchelor - 2017 - British Journal of Dermatology - Wiley Onl
Clinical trials may benefit clinical practice in three ways: firstly, clinicians may change their practice according to the new trial evidence; secondly, clinical processes can improve when working on a trial; and thirdly, research capacity is increased. We held a meeting to present and discuss the results of two large multicentre randomized controlled trials delivered through the U.K. Dermatology Clinical Trials Network.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with K. E.
Contact K. E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack